首页> 外文期刊>Surgery Research and Practice >Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn’s Disease: A Comparative Pilot Study
【24h】

Levels of Intestinal Inflammation and Fibrosis in Resection Specimens after Preoperative Anti-Tumor Necrosis Factor Alpha Treatment in Patients with Crohn’s Disease: A Comparative Pilot Study

机译:克罗恩疾病患者术前抗肿瘤坏死因子α治疗术后肠炎和纤维化水平:比较试验研究

获取原文
           

摘要

Background. Strictures are a common complication in Crohn’s disease (CD), found in more than 50% of patients. They are characterized by the excessive deposition of extracellular proteins in the tissue as a result of the chronic inflammatory process. The effect of anti-tumor necrosis factor alpha (TNF-α) therapy on the development of fibrosis is not yet fully understood. Aim. To investigate whether the degree of intestinal inflammation and fibrosis is correlated with preoperative anti-TNF-α therapy in patients with CD who are undergoing bowel resection. Methods. This unblinded, prospective, single tertiary center, pilot cohort study included all adult patients with CD who underwent elective, laparoscopic, or open intestinal resection. Preoperative investigations included measurement of blood TNF-α concentration, specific antidrug antibodies, and the concentration of selected inflammatory cytokines. Three pathologists independently examined the specimens and assessed the degree of inflammation and fibrosis. Results. Histopathological specimens from 10 patients with CD who underwent ileocecal or ileocolic resections were retrieved. Four of those patients were on anti-TNF-α treatment prior to surgery. The last dose of the anti-TNF-α agent was administered 1–9 weeks prior to bowel resection. Patients on anti-TNF-α treatment had a higher fibrosis score than controls (p=0.01). Anti-TNF-α treatment was not associated with an increase in CD68- or CD163-positive macrophages. There was no significant relationship between the time from the final preoperative anti-TNF-α dose to surgery and the fibrosis score. No significant association was found between the concentration of major inflammatory cytokines, including TNF-α, and the fibrosis score or degree of inflammation. Conclusions. Patients who underwent preoperative anti-TNF-α treatment had a higher fibrosis score than controls.
机译:背景。狭窄是克罗恩病(CD)的常见并发症,超过50%的患者。它们的特征在于由于慢性炎症过程而过度沉积组织中的细胞外蛋白。抗肿瘤坏死因子α(TNF-α)治疗对纤维化发育的影响尚未完全理解。目标。为了研究肠炎症和纤维化的程度与正在进行肠切除的CD患者的术前抗TNF-α治疗相关。方法。这种无粘性的,前瞻性,单三级中心,试点队列研究包括所有成年患者接受选修,腹腔镜或开放的肠道切除术。术前调查包括血液TNF-α浓度,特异性抗皱抗体的测量和所选炎症细胞因子的浓度。三位病理学家独立检查标本并评估炎症和纤维化程度。结果。检索来自10名CD患者的组织病理学标本,接受了接受了同性全的CD患者。这些患者中的四种患者在手术前抗TNF-α治疗。在排便前1-9周施用最后剂量的抗TNF-α剂。抗TNF-α治疗患者具有比对照的纤维化得分更高(P = 0.01)。抗TNF-α治疗与CD68-或CD163阳性巨噬细胞的增加无关。从最终术前抗TNF-α剂量与手术和纤维化分数之间没有显着的关系。在具有TNF-α的主要炎症细胞因子的浓度之间没有显着关联,包括TNF-α,纤维化得分或炎症程度之间。结论。经过术前抗TNF-α治疗的患者比对照更高的纤维化分数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号